Company profile: QPS
1.1 - Company Overview
Company description
- Provider of GLP/GCP-compliant contract research services spanning discovery, preclinical and clinical drug development, including neuropharmacology, DMPK, toxicology, bioanalysis, translational medicine, and clinical development support.
Products and services
- Clinical Development: GCP-compliant support in conducting clinical trials to assess new drugs' efficacy and safety, delivering full-service clinical drug development activities across operations in the US, Europe, India, and Asia
- Bioanalysis: GLP-compliant quantitative measurement of drugs and their metabolites in biological systems, supplying discovery and preclinical bioanalysis services central to QPS’s full-service CRO offering
- DMPK (Drug Metabolism and Pharmacokinetics): GLP-compliant services characterizing the absorption, distribution, metabolism, and excretion of compounds, producing pharmacokinetic data for discovery and preclinical drug development programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to QPS
BioBridges
HQ: United States
Website
- Description: Provider of flexible expertise, services, and technologies for life sciences companies from discovery through commercialization, offering clinical operations, data management, regulatory affairs, safety & pharmacovigilance, biostatistics, and medical affairs to support studies, compliance, safety, and post-approval lifecycle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioBridges company profile →
AmbioPharm
HQ: United States
Website
- Description: Provider of peptide manufacturing and development services, including GMP and non-GMP custom peptide synthesis via solid phase, solution phase, or hybrid processes. Manufactures active pharmaceutical ingredients and generic peptides, develops research-grade complex peptides, and offers analytical development and validation for HPLC/UPLC, serving pre-clinical, medicinal, and toxicology programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AmbioPharm company profile →
Selcia
HQ: United States
Website
- Description: Provider of integrated drug discovery services and high quality 14C radiolabelled compounds to pharma, biotechnology companies and academia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Selcia company profile →
Sterigenics
HQ: United States
Website
- Description: Provider of contract sterilization and ionization supply chain management solutions for medical device and pharmaceutical industries, using Ethylene Oxide (EO), Gamma and Electron Beam (E-Beam) irradiation. Also offers process capabilities for food safety and high performance specialty materials, VeriCycle automated EO process verification, and Sterigenics GPS end-to-end, real-time global processing status visibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterigenics company profile →
Liverpool ChiroChem
HQ: United Kingdom
Website
- Description: Provider of chiral small molecules for biotech/pharma R&D, offering specialist building blocks, fragments and screening compounds to enable small molecule drug discovery, plus ultra-large (1.4B), covalent (800k) and kinase-focused (4.5M) virtual libraries, DEL synthons, heterobifunctional linkers, and a parallel synthesis lab producing up to 5,000 compounds per month.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liverpool ChiroChem company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for QPS
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to QPS
2.2 - Growth funds investing in similar companies to QPS
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for QPS
4.2 - Public trading comparable groups for QPS
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →